O	0	1	[	[	(	O
O	1	11	Expression	Expression	NN	B-NP
O	12	14	of	of	IN	B-PP
O	15	21	Merlin	Merlin	NN	B-NP
O	22	29	protein	protein	NN	I-NP
O	30	32	in	in	IN	B-PP
B-Cancer	33	36	non	non	AFX	B-NP
I-Cancer	36	37	-	-	HYPH	I-NP
I-Cancer	37	42	small	small	JJ	B-NP
I-Cancer	43	47	cell	cell	NN	I-NP
I-Cancer	48	52	lung	lung	NN	I-NP
I-Cancer	53	62	carcinoma	carcinoma	NN	I-NP
O	63	66	and	and	CC	O
O	67	70	the	the	DT	B-NP
O	71	79	clinical	clinical	JJ	I-NP
O	80	92	significance	significance	NN	I-NP
O	92	93	]	]	)	O
O	93	94	.	.	.	O

O	96	105	OBJECTIVE	OBJECTIVE	NN	B-NP
O	105	106	:	:	:	O
O	107	109	To	To	TO	B-VP
O	110	119	determine	determine	VB	I-VP
O	120	123	the	the	DT	B-NP
O	124	134	expression	expression	NN	I-NP
O	135	138	and	and	CC	O
O	139	147	clinical	clinical	JJ	B-NP
O	148	160	significance	significance	NN	I-NP
O	161	163	of	of	IN	B-PP
O	164	170	Merlin	Merlin	NN	B-NP
O	171	178	protein	protein	NN	I-NP
O	179	181	in	in	IN	B-PP
B-Cancer	182	185	non	non	AFX	B-NP
I-Cancer	185	186	-	-	HYPH	I-NP
I-Cancer	186	191	small	small	JJ	B-NP
I-Cancer	192	196	cell	cell	NN	I-NP
I-Cancer	197	201	lung	lung	NN	I-NP
I-Cancer	202	208	cancer	cancer	NN	I-NP
O	209	210	(	(	(	O
B-Cancer	210	215	NSCLC	NSCLC	NN	B-NP
O	215	216	)	)	)	O
O	216	217	.	.	.	O

O	218	225	METHODS	METHODS	NNS	B-NP
O	225	226	:	:	:	O
O	227	230	The	The	DT	B-NP
O	231	241	expression	expression	NN	I-NP
O	242	244	of	of	IN	B-PP
O	245	251	Merlin	Merlin	NN	B-NP
O	252	259	protein	protein	NN	I-NP
O	260	262	in	in	IN	B-PP
O	263	265	45	45	CD	B-NP
O	266	271	cases	case	NNS	I-NP
O	272	274	of	of	IN	B-PP
B-Cancer	275	280	NSCLC	NSCLC	NN	B-NP
O	281	284	and	and	CC	O
O	285	293	adjacent	adjacent	JJ	B-NP
B-Tissue	294	300	tissue	tissue	NN	I-NP
O	301	303	of	of	IN	B-PP
B-Cancer	304	309	NSCLC	NSCLC	NN	B-NP
O	310	313	and	and	CC	O
O	314	320	normal	normal	JJ	B-NP
B-Tissue	321	325	lung	lung	NN	I-NP
I-Tissue	326	332	tissue	tissue	NN	I-NP
O	333	336	was	be	VBD	B-VP
O	337	344	checked	check	VBN	I-VP
O	345	347	by	by	IN	B-PP
O	348	368	immunohistochemistry	immunohistochemistry	NN	B-NP
O	368	369	.	.	.	O

O	370	373	The	The	DT	B-NP
O	374	382	relation	relation	NN	I-NP
O	383	390	between	between	IN	B-PP
O	391	394	the	the	DT	B-NP
O	395	405	expression	expression	NN	I-NP
O	406	408	of	of	IN	B-PP
O	409	415	Merlin	Merlin	NN	B-NP
O	416	423	protein	protein	NN	I-NP
O	424	427	and	and	CC	O
O	428	431	the	the	DT	B-NP
O	432	440	multiple	multiple	JJ	I-NP
O	441	448	factors	factor	NNS	I-NP
O	449	451	of	of	IN	B-PP
O	452	464	pathological	pathological	JJ	B-NP
O	465	469	type	type	NN	I-NP
O	469	470	,	,	,	O
O	471	477	gender	gender	NN	B-NP
O	477	478	,	,	,	O
O	479	480	P	P	NN	B-NP
O	480	481	-	-	HYPH	I-NP
O	481	484	TNM	TNM	NN	I-NP
O	485	490	stage	stage	NN	I-NP
O	490	491	,	,	,	O
O	492	507	differentiation	differentiation	NN	B-NP
O	508	511	and	and	CC	O
B-Multi-tissue_structure	512	517	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	518	522	node	node	NN	I-NP
O	523	533	metastasis	metastasis	NN	I-NP
O	534	537	was	be	VBD	B-VP
O	538	546	analyzed	analyze	VBN	I-VP
O	546	547	.	.	.	O

O	548	555	RESULTS	RESULTS	NNS	B-NP
O	555	556	:	:	:	O
O	557	560	The	The	DT	B-NP
O	561	571	expression	expression	NN	I-NP
O	572	577	rates	rate	NNS	I-NP
O	578	580	of	of	IN	B-PP
O	581	587	Merlin	Merlin	NN	B-NP
O	588	595	protein	protein	NN	I-NP
O	596	598	in	in	IN	B-PP
B-Cancer	599	604	NSCLC	NSCLC	NN	B-NP
O	605	608	and	and	CC	O
O	609	615	normal	normal	JJ	B-NP
B-Multi-tissue_structure	616	620	lung	lung	NN	I-NP
I-Multi-tissue_structure	621	627	tissue	tissue	NN	I-NP
I-Multi-tissue_structure	628	636	sections	section	NNS	I-NP
O	637	641	were	be	VBD	B-VP
O	642	644	73	73	CD	B-NP
O	644	645	.	.	.	O
O	645	647	33	33	CD	B-NP
O	647	648	%	%	NN	I-NP
O	649	652	and	and	CC	O
O	653	655	15	15	CD	B-NP
O	655	656	.	.	.	O
O	656	658	56	56	CD	B-NP
O	658	659	%	%	NN	I-NP
O	659	660	,	,	,	O
O	661	673	respectively	respectively	RB	B-ADVP
O	674	675	(	(	(	O
O	675	676	P	P	NN	B-NP
O	676	677	<	<	SYM	B-ADJP
O	677	678	0	0	CD	B-NP
O	678	679	.	.	.	I-NP
O	679	681	05	05	CD	I-NP
O	681	682	)	)	)	O
O	682	683	.	.	.	O

O	684	687	The	The	DT	B-NP
O	688	698	expression	expression	NN	I-NP
O	699	701	of	of	IN	B-PP
O	702	708	Merlin	Merlin	NN	B-NP
O	709	716	protein	protein	NN	I-NP
O	717	720	was	be	VBD	B-VP
O	721	724	not	not	RB	I-VP
O	725	735	associated	associate	VBN	I-VP
O	736	740	with	with	IN	B-PP
O	741	744	the	the	DT	B-NP
O	745	757	pathological	pathological	JJ	I-NP
O	758	762	type	type	NN	I-NP
O	762	763	,	,	,	O
O	764	770	gender	gender	NN	B-NP
O	770	771	,	,	,	O
O	772	773	P	P	NN	B-NP
O	773	774	-	-	HYPH	I-NP
O	774	777	TNM	TNM	NN	I-NP
O	778	783	stage	stage	NN	I-NP
O	783	784	,	,	,	O
O	785	800	differentiation	differentiation	NN	B-NP
O	801	804	and	and	CC	O
B-Multi-tissue_structure	805	810	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	811	815	node	node	NN	I-NP
O	816	826	metastasis	metastasis	NN	I-NP
O	827	828	(	(	(	O
O	828	829	P	P	NN	B-NP
O	829	830	>	>	SYM	B-ADJP
O	830	831	0	0	CD	B-NP
O	831	832	.	.	.	I-NP
O	832	834	05	05	CD	I-NP
O	834	835	)	)	)	O
O	835	836	.	.	.	O

O	837	847	CONCLUSION	CONCLUSION	NN	B-NP
O	847	848	:	:	:	O
O	849	855	Merlin	Merlin	NN	B-NP
O	856	863	protein	protein	NN	I-NP
O	864	869	might	might	MD	B-VP
O	870	880	contribute	contribute	VB	I-VP
O	881	883	to	to	TO	B-PP
O	884	887	the	the	DT	B-NP
O	888	898	initiation	initiation	NN	I-NP
O	899	901	of	of	IN	B-PP
O	902	912	metastasis	metastasis	NN	B-NP
O	913	915	of	of	IN	B-PP
B-Cancer	916	921	NSCLC	NSCLC	NN	B-NP
O	921	922	.	.	.	O

